Pharmaceutical Group Leaders:

Drew Lowery, Ph.D.
Dr. Lowery has led and worked on projects representing a wide array of technologies, such as single molecule nucleic acid amplification and sequencing, pharmaceutical formulation and dosing, satiety hormones, microfludics integrated systems, and biofuel production, among others. He directs all biological sequence searching efforts and specializes in cost efficient strategies for complicated cases. Dr. Lowery launched the Accelerated Examination Support practice, where his searches have been favorable reviewed by the USPTO, leading to patent granting for his clients. Dr. Lowery holds a Ph.D. in Biochemistry from the Massachusetts Institute of Technology where he studied cancer signaling networks.

Maxim Pometun, Ph.D.
Dr. Pometun has led and worked on projects representing a wide array of technologies, such as small molecules, polymers, petrochemicals, industrial processes, drug delivery platforms and inorganic materials, among others. He directs all chemical structure searching efforts, including Markush structure and chemical reaction searching and specializes in cost efficient comprehensive search strategies in support of FTO, acquisition due diligence, prior art, and IP landscape analysis projects for clients in the Pharmaceutical, Chemical and Biotechnology industries. Dr. Pometun received a Ph.D. in Chemistry from the University of Louisville where he studied dynamics of structural hydrates in small molecules and fibrous proteins.

Additional Expertise:

David Adamovich, Ph.D.
Ph.D. in Biological and Biomedical Sciences, Harvard University
Expertise in microbiology, genomics, therapeutic formulations

Marta Garcia, B.S.
B.S. in Materials Science and Engineering, Massachusetts Institute of Technology
Expertise in biological and polymeric materials, drug delivery

Chie Nakamura, Ph.D.
Ph.D. in Natural Sciences, Freie University
Expertise in drug delivery, material sciences

Daniel Neuman, Ph.D.
Ph.D. in Chemistry, University of California, Santa Barbara
Expertise in drug delivery platforms, polymers, organometallics